Health Tech early stage (below $10 million) investing grew consistently from 2010 – 2017, but then stalled in 2018 showing declining deal count in every quarter over the previous year. At the same time, total capital invested was flat. Was it a correction?
Results from Q1 2019 show the segment is back on the growth track. Deal counts won’t yet match 2016 and 2017 levels, but they will be up from 2018 and capital invested in U.S. early stage health tech is likely to be the highest on record.
{iframe}https://www.inovapha.org/resources/reports/health-tech-early-stage-funding-snapshot/{/iframe}